HCFA: Medicaid Must Now Cover Growth Hormone
HCFA: Medicaid Must Now Cover Growth Hormone
MANAGED CARE May 1999. ©1999 Stezzi Communications
The Health Care Financing Administration has ordered Medicaid to cover Serostim, a growth hormone that can stifle cachexia — also known to AIDS patients as wasting.... Two New York representatives have introduced a measure in Congress that would require health plans to cover routine breast, cervical, colorectal, and prostate cancer screenings under Medicare's screening-benefit schedule.... Florida legislators were to consider compromise legislation in late April mandating coverage of bone-marrow transplants, autism-spectrum disease, and oral contraceptives, all of which would add $40 million to costs, HMOs say.... The California legislature is considering a similar bill regarding coverage of oral contraceptives.... Meanwhile, California officials have told Health Net not to cut 14 drugs from its formulary, including Prozac and two drugs for cystic fibrosis that patient groups say have no adequate substitutes.
Our other journal
P&T Journal for November 2014
Features

LETTER TO THE EDITOR
Medications for Parkinson’s Disease
PERSPECTIVE
The Changing Roles of P&T Committees
Epilepsy Management: Newer Agents, Unmet Needs, and Future Treatment Strategies
PIPELINE PLUS
Modest Growth Seen in Epilepsy Market
MEETING HIGHLIGHTS
European Society of Cardiology and Transcatheter Cardiovascular Therapeutics
BOOK REVIEW
“Generic: The Unbranding of Modern Medicine,” by Jeremy A. Greene, MD, PhD
DEPARTMENTSMEDICATION ERRORS
Misadministration of IV Insulin Associated With Dose Measurement And Hyperkalemia Treatment
PRESCRIPTION: WASHINGTON
FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds
New Drugs/Drug News
Pharmaceutical Approval Update
DRUG FORECAST
Riociguat (Adempas): a Novel Agent For the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension